Hans Caspary, MD
Otolaryngology · Panama City, FLNPI 1376581041
Payments from drug & device makers
Across 105 payments — averaging $66.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$3K
- Inspire Medical Systems, Inc.$3K
- Intersect ENT, Inc.$406
- Acclarent, Inc$261
- Sanofi$170
- Regeneron Healthcare Solutions, Inc.$122
- plus $415 from 8 others
What the payments were for
- Consulting fees$401%
- Speaking & faculty fees$1,50022%
- Travel & lodging$2,35434%
- Food & beverage$3,05144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 12 | $2,894 |
| Inspire Medical Systems, Inc. | 46 | $2,677 |
| Intersect ENT, Inc. | 12 | $406 |
| Acclarent, Inc | 11 | $261 |
| Sanofi | 7 | $170 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| AstraZeneca | 1 | $115 |
| Smith+Nephew | 4 | $97 |
| Medtronic | 2 | $68 |
| Integra Lifesciences Corporation | 2 | $45 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Stryker | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| GSK | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,587
- VIVAER STYLUS$1,500
- RHINAER STYLUS$1,500
- Vivaer RF Stylus$1,086
- AIRSUPRA$115
How this compares
$6,946 in reported general payments places this provider in the 80th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 34 | $1,191 |
| Azelastine Hcl | 18 | $834 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $609 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $522 |
| Ofloxacin | 24 | $433 |
| Azithromycin | 55 | $280 |
| Sucralfate | 15 | $269 |
| Fluticasone Propionate | 14 | $198 |
| Omeprazole | 15 | $167 |
| Ondansetron OdtOndansetron | 37 | $160 |
| Methylprednisolone | 14 | $147 |
| CefuroximeCefuroxime Axetil | 11 | $116 |
| Mupirocin | 15 | $101 |
| Doxycycline Hyclate | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Panama City
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
- Franklin RimellFort Myers$314K
- Tapan PadhyaTampa$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.